After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...
Investor's Business Daily on MSN4d
Why Verona Pharma, A Triple-Digit Gainer In 2024, Surged Another 19% This WeekVerona Pharma stock hit a record high Thursday on continued enthusiasm for its newly launched COPD treatment, Ohtuvayre.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback